Rob has more than 20 years of leadership experience. Before joining Rapid Micro Biosystems, he was Vice President and General Manager, Americas, for the Microbiology Division of Thermo Fisher Scientific.
Previously, Rob was the VP of Global Strategy, Marketing, and Business Development for Fisher Scientific. He’s also held senior positions at McKesson Corporation and its affiliates, including EVP Operations and Development and National Vice President of Sales and Business Development.
Earlier in his career, Rob was a senior consultant within the Life Sciences and Healthcare practice of Deloitte Consulting and an aviation officer with the U.S. Army.
Rob holds a BS in Economics from the United States Military Academy at West Point and an MBA from Columbia University, where he was the Dr. Donald Bibeault Scholar.
Sean has over 25 years of broad financial experience in the healthcare and technology industries. Most recently, he served as Vice President, Finance and Controller of Asia Pacific, Middle East and Africa (AMEA) for Boston Scientific, a manufacturer of medical devices. In this role, he led all aspects of financial management for the AMEA region, as well as providing regional oversight for the strategic pricing, reimbursement, supply chain, and business development functions. Prior to that, he served as Vice President of Investor Relations at Boston Scientific, in progressive roles at Varian, Inc. including Vice President and Controller and Vice President, Finance and Treasurer, and as Corporate Controller at Quova. Sean began his career with PricewaterhouseCoopers, serving emerging, high-growth clients across the healthcare and technology industries.
Sean holds a BS in Accounting from the Carroll School of Management at Boston College. He is a Certified Public Accountant and a member of Financial Executives International (FEI) and the Association of Financial Professionals (AFP).
Scott has over 20 years of sales experience in the healthcare and technology industries. He spent 7 years in progressive roles at Intuitive Surgical (NASDAQ:ISRG), including Area Vice President for the US Southeast / Mid-Atlantic region. In this role, he led a 120-member sales team across 7 states and 270+ hospitals, growing the region to consecutive #3 and #2 rankings in worldwide sales, and #1 in new technology sales, and generating $200 million in revenue. Scott has also served as President of Compass Surgical Partners, a private firm that manages ambulatory surgical centers, Managing Partner of Surgery Center Development Co, a multi-specialty outpatient surgical center business, and in multiple sales roles at C.R. Bard, GlaxoSmithKline and Verizon.
Scott holds an MBA in Finance from the University of Miami, and a BS in Business Administration from the University of Florida.
Steven brings more than 25 years of customer service experience in the medical device and diagnostics industry. Most recently, he held the position of Senior Director of Service Transformation in Latin America at bioMérieux, where he focused on standardization and optimization of service delivery in a high sales growth region.
Steven held multiple service and operations leadership roles at bioMérieux, including managing a team of almost 200 customer support, field application, and field service employees. Steven's prior roles included positions at Organon Teknika Corp and with the United States Navy.
Steven holds a BS in Business Management and an MBA from the University of Phoenix
Mike has over 26 years of Operations and Operations leadership in the Medical Device Industry and joins Rapid Micro Biosystems most recently from Smiths Medical, where he was Vice President Operations - North America, responsible for eight manufacturing plants in the U.S. and Mexico.
Previously, Mike held senior Operations leadership roles at Medtronic Corporation, Tyco Healthcare, and Cordis Corporation. Mike brings with him a strong track record of turning around operations, developing and executing Manufacturing Footprint and Network Optimization Strategy, and driving product cost improvements.
Mike Holds a B.S. in Electrical Engineering from Northeastern University, an MBA from Nova Southeastern University, and a M.S. in Mechanical Engineering from Columbia University.
Jim brings more than 30 years of quality control and quality operations experience in the engineering and medical device industry. Most recently, he held the position of Vice President of Operations and Quality at American Science & Engineering, where he successfully developed and managed the quality management system, implemented Lean tools and methodologies, and significantly improved quality, manufacturing, and supply chain operations.
Previously, Jim held multiple quality positions at American Science & Engineering, including VP, Sustaining Engineering and Quality; VP, Quality; and, Director, Quality. Jim’s prior experience includes positions at Progressive Technologies, Neslab Instruments, and Lawrence Pumps Inc.
Jim holds a BS in Mechanical Engineering from Worcester Polytechnic Institute.
Cameron has more than 15 years experience in Life and analytical sciences and medical devices in a range of global positions with increasing seniority in R&D, quality/regulatory, marketing, sales management and executive leadership. Cameron was most recently at Agilent Technologies where his most recent roles included VP/GM of the laboratory enterprise division and senior director of the global strategic account program. Cameron has also held advisory roles in molecular and clinical diagnostics and board level roles.
He holds degrees in business, engineering technology, information systems and an MBA.
Andrew brings more than 10 years of industry experience across venture capital and strategy consulting. He joined Rapid Micro Biosystems most recently from Quaker Partners, a venture capital firm investing in life science companies, where he was Vice President. As part of the investment team, he evaluated and completed investments in pharmaceutical, biotech, diagnostics, and healthcare IT companies, and served as a board observer for several portfolio companies.
Previously, Andrew was a consultant with Leerink Swann, a life sciences consulting firm providing strategic advisory services to global pharmaceutical, biotech, and medical device companies.
Andrew holds a BA in biology from Harvard College.